KCNC3: phenotype, mutations, channel biophysics-a study of 260 familial ataxia patientsA systematic review of epileptic seizures in adults with subdural haematomas.[Brivaracetam for add-on treatment in focal epilepsy].Lacosamide in status epilepticus: Systematic review of current evidence.Guideline conform initial monotherapy increases in patients with focal epilepsy: A population-based study on German health insurance data.Seizures induced by the sight of moving water.Ictal asystole in temporal lobe epilepsy before and after pacemaker implantation.Management and long-term outcome in patients presenting with ictal asystole or bradycardia.Localizing and lateralizing value of ictal flatulence.Treatment of paroxysmal dyskinesias.[New aspects in the field of epilepsy].Adjunctive retigabine in refractory focal epilepsy: Postmarketing experience at four tertiary epilepsy care centers in Germany.Cost of epilepsy: a systematic review.The efficacy of lacosamide as monotherapy and adjunctive therapy in focal epilepsy and its use in status epilepticus: clinical trial evidence and experienceCost of status epilepticus: A systematic review.The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study.Perampanel in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.Costs, length of stay, and mortality of super-refractory status epilepticus: A population-based study from Germany.Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.Predictors of and attitudes toward counseling about SUDEP and other epilepsy risk factors among Austrian, German, and Swiss neurologists and neuropediatricians.The history of invasive EEG evaluation in epilepsy patients.Treatment of refractory and super-refractory status epilepticus with brivaracetam: A cohort study from two German university hospitals.Estimating the Quantitative Demand of NOAC Antidote Doses on Stroke Units.Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany.Neurologist adherence to clinical practice guidelines and costs in patients with newly diagnosed and chronic epilepsy in Germany.Revised version of quality guidelines for presurgical epilepsy evaluation and surgical epilepsy therapy issued by the Austrian, German, and Swiss working group on presurgical epilepsy diagnosis and operative epilepsy treatment.Teaching NeuroImages: spontaneous asymptomatic occlusion of a cerebral arteriovenous malformation.Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in Germany.Stiripentol for the treatment of super-refractory status epilepticus.Evaluation of costs of epilepsy using an electronic practice management software in Germany.Sustained seizure remission on perampanel in progressive myoclonic epilepsy (Lafora disease).Ictal conduction aphasia and ictal angular gyrus syndrome as rare manifestations of epilepsy: The importance of ictal testing during video-EEG monitoring.Association of time-to-levodopa with initial Parkinsonian medication: a retrospective cohort study.Socioeconomic Outcome and Quality of Life in Adults after Status Epilepticus: A Multicenter, Longitudinal, Matched Case-Control Analysis from Germany.Six months of postmarketing experience with adjunctive lacosamide in patients with pharmacoresistant focal epilepsy at a tertiary epilepsy center in Germany.Counseling and social work for persons with epilepsy: observational study on demand and issues in Hessen, Germany.Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany--a nationwide population-based study in children and adults.Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany.Postictal increase in T-wave alternans after generalized tonic-clonic seizures.Quality of life and employment status are correlated with antiepileptic monotherapy versus polytherapy and not with use of "newer" versus "classic" drugs: results of the "Compliant 2006" survey in 907 patients.
P50
Q24324107-92BCA29C-EEE0-4E70-BF69-E28C7B6E7FF3Q30240210-BE013534-60A8-407D-B124-598B7278586CQ30390285-141DF767-2440-48A2-BA73-E3B02C9DF549Q30399934-C05760AC-3F45-4CDB-9F70-2D267D3DCAFEQ31115161-00A81E3E-0FF7-40B8-AA20-3CC5C120E4ECQ31150668-321719F1-5323-4B86-A668-274688C92D0CQ33156112-0D7BB7B5-0461-49DD-A91D-E428AAE60CC4Q33159721-B919E947-0A94-4714-B03D-40E297C34F04Q33444816-62548B3E-9837-49C7-A840-4D79E94A5CD0Q34151861-37020AD0-9BE5-4326-A7B2-A43443C33429Q35206626-AD59187C-23F3-4C6C-99A2-FC852271C9E9Q35909508-7CDDF1A5-4DE6-45E6-8862-4809AB3BE67DQ37167568-2B8B9BD3-862E-4624-B4F0-9E6EA6A70384Q37722778-3D569EDB-5B15-4EBF-9167-54C385D900E1Q38309482-AF0F4979-E1C0-4220-8941-9E573E24E67CQ38471476-25935D27-0C3C-41AD-9383-9647502A7C1AQ38599106-35D55CD3-7881-4FDF-9FA5-1E7E3FC8E2F2Q38691719-E1152DD4-7C31-47CF-87E7-40045669C16BQ38739649-74E02DF1-36E3-4667-BDB6-971378976AC9Q38743191-F3BDE1CB-91A0-492D-86CB-7D798B5EDCEEQ38821837-6B797850-20BA-4547-A24F-8B112A79C939Q38828381-0F771E61-4966-4AA8-8575-6CA03BA4B9CDQ38839745-3E1893FD-14AA-47C6-A27F-1CB4B9B090B1Q39278813-8D8D99BB-24C6-44F0-A8F1-FF7BF7FEA240Q39298911-01A8B9F0-6D7D-4F6D-A282-652AA5FAFA46Q39647237-1EA48F6A-72A5-470D-98A2-A6E90FC15DA9Q39937395-8BB08275-2271-4026-A9B2-DD94751B86D7Q40667644-3151D777-1551-4A3C-8E86-C123A7A39A4EQ41159617-C5C6743C-BDFF-4187-BADA-8E4DADF46BC9Q41177223-2E3AFCD4-39C9-4F9C-A1F0-9B8455A7CB72Q41455462-BB8F9C27-3467-4130-89A6-A2A7AC260D9BQ41634581-0CF539B7-143D-4EC0-94C2-9F57DD59D4DDQ41642648-6A768FEE-AD5F-40CE-B20B-FCD2FF0585A2Q42368392-D324E7D9-6027-4FCD-A25F-CAB748378172Q43273962-50F02E5F-6D56-41C5-A95A-04387A76945CQ43816943-EFF7AD6A-4D89-490F-AA6F-33EC3B2342CAQ43843541-717A7283-9421-44CD-AABE-281CB06C2F49Q44162001-89A8E664-50D1-4DCE-8F2D-852B7B9A41DFQ44372496-FB574571-B494-4395-A815-B4F48E1CD787Q44452689-AA490F61-8226-46C9-A00B-7F665EEB27B8
P50
description
polnisch-deutscher Neurologe und Epileptologe
@de
profesor universitario polaco
@es
profesor universitario polaco
@gl
profesor universitariu polacu
@ast
professeur d'université polonais
@fr
professor d'universitat polonès
@ca
professor universitário polaco
@pt
professore universitario polacco
@it
researcher ORCID ID = 0000-0001-6288-9915
@en
unibertsitateko irakasle poloniarra
@eu
name
Adam Strzelczyk
@ast
Adam Strzelczyk
@ca
Adam Strzelczyk
@de
Adam Strzelczyk
@en
Adam Strzelczyk
@es
Adam Strzelczyk
@fr
Adam Strzelczyk
@ga
Adam Strzelczyk
@pl
Adam Strzelczyk
@sl
Adam Strzelczyk
@sq
type
label
Adam Strzelczyk
@ast
Adam Strzelczyk
@ca
Adam Strzelczyk
@de
Adam Strzelczyk
@en
Adam Strzelczyk
@es
Adam Strzelczyk
@fr
Adam Strzelczyk
@ga
Adam Strzelczyk
@pl
Adam Strzelczyk
@sl
Adam Strzelczyk
@sq
prefLabel
Adam Strzelczyk
@ast
Adam Strzelczyk
@ca
Adam Strzelczyk
@de
Adam Strzelczyk
@en
Adam Strzelczyk
@es
Adam Strzelczyk
@fr
Adam Strzelczyk
@ga
Adam Strzelczyk
@pl
Adam Strzelczyk
@sl
Adam Strzelczyk
@sq
P214
P227
P106
P1153
24067864600
P19
P21
P213
0000 0000 1941 4212
P214
P227
P27
P31
P496
0000-0001-6288-9915
P569
1978-08-01T00:00:00Z
P734
P735
P7859
viaf-50439009